Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MADRIGAL PHARMACEUTICALS, INC. | General Counsel | Common Stock | 10.5K | $3.51M | $335.00 | Mar 5, 2025 | Direct |
MADRIGAL PHARMACEUTICALS, INC. | General Counsel | Stock Option (Right to Buy) | 5.37K | Mar 5, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Mar 5, 2025 | 2 | $0 | 4 | Mar 7, 2025 | General Counsel |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Mar 3, 2025 | 1 | -$139K | 4 | Mar 5, 2025 | General Counsel |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Jan 17, 2025 | 1 | -$75.7K | 4 | Jan 17, 2025 | General Counsel |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Aug 15, 2024 | 2 | $0 | 4 | Aug 19, 2024 | General Counsel |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Aug 5, 2024 | 0 | $0 | 3 | Aug 15, 2024 | General Counsel |